Schnell, Oliver

Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

Shi, Q., Nong, K., Vandvik, P. O., Guyatt, G. H., Schnell, O., Rydén, L., Marx, N., Brosius, F. C., Mustafa, R. A., Agarwal, A., et al. (2023) · BMJ

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 293

Postprandial Hyperglycemia and Glycemic Variability

Standl, E., Schnell, O., & Ceriello, A. (2011) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 183

New insights into the treatment of obesity

Blüher, M., Aras, M., Aronne, L. J., Batterham, R. L., Giorgino, F., Ji, L., Pietiläinen, K. H., Schnell, O., Tonchevska, E., & Wilding, J. P. H. (2023) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 158

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology

On behalf of the EUROASPIRE Investigators, Gyberg, V., De Bacquer, D., De Backer, G., Jennings, C., Kotseva, K., Mellbin, L., Schnell, O., Tuomilehto, J., Wood, D., et al. (2015) · Cardiovascular Diabetology

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 140

Interferences and Limitations in Blood Glucose Self-Testing: An Overview of the Current Knowledge

Erbach, M., Freckmann, G., Hinzmann, R., Kulzer, B., Ziegler, R., Heinemann, L., & Schnell, O. (2016) · Journal of Diabetes Science and Technology

Diabetes Management and ResearchClinical Laboratory Practices and Quality Control

Cited by 115

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV

Shahim, B., De Bacquer, D., De Backer, G., Gyberg, V., Kotseva, K., Mellbin, L., Schnell, O., Tuomilehto, J., Wood, D., & Rydén, L. (2017) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 114

Self-Monitoring of Blood Glucose in Type 2 Diabetes: Recent Studies

Schnell, O., Alawi, H., Battelino, T., Ceriello, A., Diem, P., Felton, A.-M., Grzeszczak, W., Harno, K., Kempler, P., Satman, I., et al. (2013) · Journal of Diabetes Science and Technology

Diabetes Management and ResearchDiabetes Management and Education

Cited by 88

Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease—a persistent challenge in need of substantial improvement: a report from ESC EORP EUROASPIRE V

Ferrannini, G., De Bacquer, D., De Backer, G., Kotseva, K., Mellbin, L., Wood, D., Rydén, L., collaborators, E. V., Gale, C. P., Beleslin, B., et al. (2020) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 75

Consensus Report of the Coalition for Clinical Research—Self-Monitoring of Blood Glucose

Klonoff, D. C., Bergenstal, R., Blonde, L., Boren, S. A., Church, T. S., Gaffaney, J., Jovanovič, L., Kendall, D. M., Kollman, C., Kovatchev, B. P., et al. (2008) · Journal of Diabetes Science and Technology

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 74

High prevalence of diagnosed and undiagnosed polyneuropathy in subjects with and without diabetes participating in a nationwide educational initiative (PROTECT study)

Ziegler, D., Strom, A., Lobmann, R., Reiners, K., Rett, K., & Schnell, O. (2015) · Journal of Diabetes and its Complications

Diabetic Foot Ulcer Assessment and ManagementPeripheral Neuropathies and Disorders

Cited by 48

Addressing Schemes of Self-Monitoring of Blood Glucose in Type 2 Diabetes: A European Perspective and Expert Recommendation

Schnell, O., Alawi, H., Battelino, T., Ceriello, A., Diem, P., Felton, A., Grzeszczak, W., Harno, K., Kempler, P., Satman, I., et al. (2011) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 47

What should be the antihypertensive drug of choice in diabetic patients and should we avoid drugs that increase glucose levels? Pro and Cons

Standl, E., Erbach, M., & Schnell, O. (2012) · Diabetes/Metabolism Research and Reviews

Blood Pressure and Hypertension StudiesDiabetes Treatment and Management

Cited by 20